Table 3.
Group A (n=40) | Group B (n=48) | χ2 | P | |
---|---|---|---|---|
Edema | 0 (0.00) | 1 (2.08) | - | - |
Nausea | 1 (2.50) | 1 (2.08) | - | - |
Hypoglycemia | 0 (0.00) | 1 (2.08) | - | - |
Incidence of adverse reactions | 2 (5.00) | 3 (20.83) | 0.064 | 0.801 |
Group A (n=40) | Group B (n=48) | χ2 | P | |
---|---|---|---|---|
Edema | 0 (0.00) | 1 (2.08) | - | - |
Nausea | 1 (2.50) | 1 (2.08) | - | - |
Hypoglycemia | 0 (0.00) | 1 (2.08) | - | - |
Incidence of adverse reactions | 2 (5.00) | 3 (20.83) | 0.064 | 0.801 |